Technology Profits Confidential

The world of tech and biotechnology will provide endless opportunity for growth and wealth for investors who know where to look.

Technology Profits Confidential is your one-stop shop for the companies of tomorrow's technology... and how you can profit from them.

Supreme Court Patent Ruling Will Have Little Impact on Our Gene Innovators

As you've probably heard, the U.S. Supreme Court unanimously ruled that naturally occurring human genes cannot be patented. I've been getting some questions on the impact of this ruling. The case was brought against Myriad Genetics, which claimed a patent on the BRCA1 and BRCA2 genes. Mutations in these genes are important markers for breast cancer risk and were used in Myriad's diagnostic tests. Others sued Myriad because they wanted the right to use these genes in their own tests.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

LoginGet Access

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, Ray Blanco’s FDA Trader, Penny Pot Profits, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco